Gridina N, Khokhlov A, Zvyagintseva T, M. I, Khrystosenko R, K. L, Belousova A, Guk A, V. E
{"title":"Development of prospects for adjuvant treatment of malignant brain tumors in experiments on C6 glioma","authors":"Gridina N, Khokhlov A, Zvyagintseva T, M. I, Khrystosenko R, K. L, Belousova A, Guk A, V. E","doi":"10.54646/bijnn.2023.11","DOIUrl":"https://doi.org/10.54646/bijnn.2023.11","url":null,"abstract":"The treatment of malignant tumors and their postoperative relapses is largely limited by toxic manifestations from a large number of known chemotherapy drugs. Finding a way to reduce the toxicity of drugs while maintaining their antitumor activity is a major challenge. In this work, the highly toxic drug gemcitabine was diluted 100 and 10,000 times with ion-free water and, together with verapamil hydrochloride, at a dilution of 10,000 times, was studied for the ability, when used together, to influence the blood cell aggregation. Our previous studies with low concentrations of verapamil showed a satisfactory effect in the treatment of malignant brain gliomas. In an experiment with C6 glioma in Wistar rats, the blood cell aggregation (SPR indicators) was determined daily in vitro under the combined action of gemcitabine and verapamil at low concentrations. The daily effect of these drugs on the level of blood cell aggregation turned out to be very variable, which is an important argument against the use of chemotherapy drugs in doses that are narrowly limited by protocols. The study of the correlation coefficients between the surface plasmon resonance (SPR indicators) and the quantitative composition of cell fractions in rats after transplantation of C6 glioma made it possible to determine the scope of regenerative processes in the tumor tissue and its microenvironment, which can also make changes in the methods of tumor treatment.","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91317354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Can Wearing Earrings Cause Headaches?","authors":"W. L. Huang","doi":"10.54646/bijnn.007","DOIUrl":"https://doi.org/10.54646/bijnn.007","url":null,"abstract":"Introduction: Normally Western medicine studies the cause of headaches as a local manifestation and usually asks only for radiological exams to see if the cause of headaches is inside the cranial region. The aim of this study is to show that the cause of headaches can be outside the head, and it is one of the differential diagnoses that the doctor should be aware of in order to treat the patient appropriately and not only treat the symptom with anti-inflammatory drugs. Methods: Three case reports revealed headache manifestations primarily in the peri-ocular region on both sides. They all were wearing earrings in the area of the eye at the auricular point according to auricular medicine. I asked everyone to take out their earrings from the ears, and the headache manifestations ceased in 5 min. This study concludes that the cause of headaches can be outside the head of patients and that headaches could be caused by the use of earrings, mainly when they are in the region corresponding to the eye point, and that only taking out the earrings could stop the headache pain in 5 min without needing to use any kind of medication.","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"114 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76718726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammad-Reza Hosseini-Siyanaki, Zahra Hasanpour Segherlou, Sophie Liu, Mohammed A Azab, Majid Khan, Brandon Lucke-Wold
{"title":"Recurrent meningioma: When to intervene.","authors":"Mohammad-Reza Hosseini-Siyanaki, Zahra Hasanpour Segherlou, Sophie Liu, Mohammed A Azab, Majid Khan, Brandon Lucke-Wold","doi":"10.54646/bijnn.008","DOIUrl":"10.54646/bijnn.008","url":null,"abstract":"<p><p>Meningioma occurs most frequently as a benign tumor central nervous system that is common in old females. Radiation exposure and deletion of the NF2 gene are known risk factors. However, there is no consensus about the role of sex hormones. Meningiomas are usually benign tumors, but 6% can be anaplastic or atypical. Most asymptomatic patients do not require treatment, but complete surgical resection is recommended for symptomatic patients. If a tumor returns after being resected previously, it is recommended to be resected, followed by radiotherapy in some cases. Meningiomas (benign, atypical, and malignant) recurring after standard treatment fails could be treated with hormone therapy, chemotherapy, target therapy, and calcium channel blockers.</p>","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"2 1","pages":"3-11"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9552152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Spinal tumor embolization: benefit for surgical resection.","authors":"Krisna Maddy, Delano Trenchfield, Henson Destine, Vanesha Waiters, Daniel Nwatu, Brandon Lucke-Wold","doi":"10.54646/bijnn.2023.10","DOIUrl":"10.54646/bijnn.2023.10","url":null,"abstract":"<p><p>The embolization of hypervascular spinal tumors preoperatively has shown to be a worthwhile adjunctive procedure to minimize the elevated risks associated with surgical resection, such as intraoperative blood loss and its associated complications. Resection of these hypervascular tumors is necessary for local tumor control, reduction in patient-reported pain, improved neurological functioning, and spinal stability. This adjunctive procedure has been associated with improved surgical outcomes and easier facilitation of surgical resection. As such, we provide a review of the current literature examining the employment of this technique. Specifically, this article (a) reviews the techniques of embolization, with anatomical considerations of the arterial framework of the spinal network; (b) relativizes and outlines the post-embolization management of spinal tumor resection; (c) provides a critical outlook on the reported benefit of preoperative embolization before surgical resection with support from clinical studies in the literature; and (d) discusses the efficacy and reliability of provocative testing and post-procedural management and follow-up. Ultimately, a thorough and updated review of preoperative spinal tumor embolization and its clinical benefits will summarize the current fund of knowledge and encourage future research toward continued improvements in patient outcomes for those needing to undergo surgical resection of spinal lesions.</p>","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"1 2","pages":"71-80"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10008227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abdurrahman F Kharbat, Michelot Michel, Ryan D Morgan, Miguel Tusa Lavieri, Brandon Lucke-Wold
{"title":"Intracranial venous sinus thrombosis: Medical and surgical management considerations.","authors":"Abdurrahman F Kharbat, Michelot Michel, Ryan D Morgan, Miguel Tusa Lavieri, Brandon Lucke-Wold","doi":"10.54646/bijnn.2023.09","DOIUrl":"10.54646/bijnn.2023.09","url":null,"abstract":"<p><p>Cerebral venous thrombosis is a serious neurological condition characterized by thrombus formation in the venous sinuses or cerebral veins. Although rare, it is a potentially fatal condition that requires prompt diagnosis and treatment. This review aims to present the most current trends in our understanding of CVT risk factors, diagnosis, medical management, role of endovascular management, risk of intracranial hemorrhage, and emerging therapies. Most cases of CVT are diagnosed by clinical features and neuroimaging suggestive of sinus occlusion. While anticoagulation with heparin is the mainstay of medical management, direct-oral anticoagulants are emerging as a potential alternative, and severe cases have been managed successfully with thrombectomy and/or intrasinus urokinase thrombolysis. Despite recent advances in anticoagulation therapy and diagnostics, larger randomized studies are required to adequately assess these emerging therapies and better inform the management of patients suffering from CVT.</p>","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"2 1","pages":"12-23"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9939342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Swaminathan Divya, P. S, Aishvarya Shree N., Vasudevan M. C., K. G.
{"title":"Reporting A Case of Spontaneous Ocular Hypotony After the Neurosurgical Procedure","authors":"Swaminathan Divya, P. S, Aishvarya Shree N., Vasudevan M. C., K. G.","doi":"10.54646/bijnn.005","DOIUrl":"https://doi.org/10.54646/bijnn.005","url":null,"abstract":"Spontaneous ocular hypotony is a rare entity. So far in the literature, there have been few cases that report on ocular hypotony in nonocular surgery. The most common nonocular surgery causing hypotony is coronary arterial bypass grafting. It is due to wide fluctuations in blood pressure, central venous pressure, and the use of mannitol intraoperatively. In neurosurgery, previously reported cases were post-thrombectomy and post-aneurysm clipping. In one case, there was a complete occlusion of ophthalmic artery due to emboli, and in another case, it was due to a wide fluctuation in blood pressure. We are reporting a case of ocular hypotony in a patient who underwent right frontal craniotomy and excision of a metastatic lesion. In our case, intraoperatively, mannitol was used, but there were no fluctuations in blood pressure and central venous pressure. The use of mannitol was slated to be the reason for ocular hypotony.","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88478637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Riad Habib, N. Jahan, Atikur Rahman, Nafaur Rahman, E. Mahmood
{"title":"Invasive Sinu-Naso-Orbital Aspergilloma Following Dacryocystorhinostomy in an Immunocompetent Patient: A Rare Case Report and Literature Review","authors":"Riad Habib, N. Jahan, Atikur Rahman, Nafaur Rahman, E. Mahmood","doi":"10.54646/bijnn.006","DOIUrl":"https://doi.org/10.54646/bijnn.006","url":null,"abstract":"Background: Invasive sinu-naso-orbital aspergilloma is a rare disease with variable clinical features, but in an immunocompetent patient, it is rarely considered and often resulted in a poor prognosis due to its diagnostic and therapeutic challenges. In this article, we report a rare case of invasive sinu-naso-orbital aspergillosis with intracranial extension following dacryocystorhinostomy. To the best of our knowledge, this is the only reported case in the past 109 years. Case Description: A 61-year-old normotensive nondiabetic male was referred to us from an ophthalmologist with complaints of retro-orbital pain followed by progressive dimness of vision and later blindness on right eye after dacryocystorhinostomy. Diagnosis and Intervention: His MRI reveals an isointense lesion in the T1W and T2W images in the right maxillary, ethmoidal sinus with orbital and retro-orbital, and intracranial extension with heterogeneous contrast enhancement. A radiologist suggested a case of inflammatory pseudotumor, and initially he was treated with steroids due to a lack of clinical response; later, antifungal was given, but the patient still was nonresponsive. A right pterional craniotomy was performed on the patient to access the optic nerve and perform the biopsy. Aspergillus infection was seen by histopathology. Postoperatively, he was treated with voriconazole. Lessons: In immunocompetent individuals, invasive sino-orbital aspergillosis is uncommon. For effective care, early diagnosis is essential. Our advice is that a patient with vague symptoms or retro-orbital discomfort should encourage the doctor to investigate this diagnosis due to the diagnostic difficulties and greater mortality and morbidity rates. Abbreviations: DCR: dacryocystorhinostomy, PL: Perception of light, PR: Projection of rays","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"89 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85968867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Development of Transcranial Magnetic Stimulation","authors":"Bradley J. Roth","doi":"10.54646/bijnn.002","DOIUrl":"https://doi.org/10.54646/bijnn.002","url":null,"abstract":"This review describes the development of transcranial magnetic stimulation in 1985 and the research related to this technique over the following 10 years. It not only focuses on work done at the National Institutes of Health but provides a survey of other related research as well. Key topics are the calculation of the electric field produced during magnetic stimulation, the interaction of this electric field with a long nerve axon, coil design, the time course of the magnetic stimulation pulse, and the safety of magnetic stimulation.","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"79 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91401230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jasmin Nisamudeen, B. Mathew K V, Roshan Bijlee K. N
{"title":"Whole-Body vibration therapy: an overview","authors":"Jasmin Nisamudeen, B. Mathew K V, Roshan Bijlee K. N","doi":"10.54646/bijnn.2023.12","DOIUrl":"https://doi.org/10.54646/bijnn.2023.12","url":null,"abstract":"Concern has been raised about whole-body vibration training (WBVT), which activates skeletal muscles by employing vibrations rather than a mass load or dynamic exercise. As vibration massage and local vibration applied to muscles show promising benefits, vibration treatment and exercise became widely used in rehab. Studies are still being conducted to fully comprehend the cumulative impacts and long-term safety of this training program. This study gives an outline of WBVT, explaining its physiology and advantages as well as some safety aspects, contraindications, and instructions for applying it in a clinical environment.","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90252914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marco Foreman, Aashay Patel, Sohum Sheth, Akshay Reddy, Brandon Lucke-Wold
{"title":"Diabetes Mellitus Management in the Context of Cranial Tumors.","authors":"Marco Foreman, Aashay Patel, Sohum Sheth, Akshay Reddy, Brandon Lucke-Wold","doi":"10.54646/bijnn.004","DOIUrl":"10.54646/bijnn.004","url":null,"abstract":"<p><p>The study of the relationship between cancer and diabetes mellitus (DM) has been under investigation for many decades. Particularly in the field of neurology and neurosurgery, increasing emphasis has been put on the examination of comorbid DM in patients with cranial tumors. Namely, as the most common and invasive type of malignant adult brain tumor, glioblastoma (GBS) has been the focus of said research. Several mechanisms have been described in the attempt to elucidate the underlying association between DM and GBS, with the metabolic phenomenon known as the Warburg effect and its consequential downstream effects serving as the resounding culprits in recent literature. Since the effect seen in cancers like GBS exploits an upregulated form of aerobic glycolysis, the role of a sequela of DM, known as hyperglycemia, will be investigated. In particular, in the treatment of GBS, surgical resection and subsequent chemotherapy and/or radiotherapy are used in conjunction with corticosteroid therapy, the latter of which has been linked to hyperglycemia. Unsurprisingly, comorbid DM patients are significantly susceptible to this disposition. Further, this fact is reflected in recent literature that demonstrates the impact of hyperglycemia on cancer advancement and patient outcomes in several preclinical and clinical studies. Thus, this review will aim to underline the significance of diabetes and glycemic control via standard-of-care treatments such as metformin administration, as well as to describe emerging treatments such as the signaling modulation of insulin-like growth factor and the employment of the ketogenic diet.</p>","PeriodicalId":72438,"journal":{"name":"BOHR International journal of neurology and neuroscience","volume":"1 1","pages":"29-39"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9149231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}